Seeking Alpha

GlaxoSmithKline (GSK +0.4%) says it's submitted a regulatory application in the European Union...

GlaxoSmithKline (GSK +0.4%) says it's submitted a regulatory application in the European Union for umeclidinium bromide, or UMEC, an investigational once-daily medicine for patients with chronic obstructive pulmonary disease. Regulatory filings are pending in the U.S. and planned for other countries during the course of 2013.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs